金属基质蛋白酶抑制剂在冠状动脉介入术后再狭窄过程中的作用
出处
《临床荟萃》
CAS
北大核心
2006年第13期986-988,共3页
Clinical Focus
参考文献15
-
1Post MJ,de Smet BJ,van der Helm Y,et al.Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model[J].Circulation,1997,96(3):996-1003.
-
2Epstein SE,Speir E,Unger EF,et al.The basis of molecular strategies for treating coronary restenosis after angioplasty[J].J Am Coll Cardiol,1994,23(6):1278-1288.
-
3Myers PR,Webel RR,Thondapu VR.Vascular nitric oxide synthase activity following coronary artery balloon injure in a porcine restenoaia model[J].Circulation,1994,90 (suppl Ⅰ):Ⅰ139-Ⅰ141.
-
4Feldman LJ,Deux JF,Jacob MP,et al.Differential expression of matrix metalloproteinase after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit[J].Circulation,2001,103(25):3117-3122.
-
5Galt SW,Lindemann S,Allen L,et al.Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function[J].Circ Res,2002,90(10):1093-1099.
-
6Dumin JA,Dickeson SK,Stricker TP,et al.Pro-collagenase (matrix metalloproteinase -1)binds the α2β1 integrin upon release from keratinocytes migrating on type-Icollagen[J].J Biol Chem,2001,276(31):29368-29374.
-
7Stricker TP,Dumin JA,Dickeson SK,et al.Structural analysis of the α2 integrin Idomain/procollagenase-1 (matrix metallproteinase-1) interaction[J].J Biol Chem,2001,276(31):29375-29381.
-
8Masuda T,Nakayama Y.Development of a water-soluble matrix metalloproteinase inhibitor as an intra-arterial infusion drug for prevention of restenosis after angioplasty[J].J Med Chem,2003,46(16):3497-3501.
-
9de Smet BJ,de Kleijin D,Hanemaaijer R,et al.Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty:a study in the atherosclerotic Yucatan micropig[J].Circulation,2000,101(25):2962-2967.
-
10Webb KE,Henney AM,Anglin S,et al.Expression of matrix metalloproteinase and their inhibitor TIMP-1 in the rat carotid artery after balloon injury[J].Arterioscler Thromb Vasc Biol,1997,17(9):1837-1844.
二级参考文献4
-
1柳英侠,毕延发,张淑芹,郑海红,孙宝贵.定位性动脉粥样硬化狭窄模型的复制[J].哈尔滨医科大学学报,1997,31(2):161-162. 被引量:1
-
2Petersen E, Wagberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture.Eur J Vasc Endovasc Surg,2002,23:153-157.
-
3Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol, 1998,32:368-372.
-
4Feldman LJ, Deux JF,Jacob MP, et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit.Circulation,2001,103:3117-3122.
共引文献5
-
1顾俊,王长谦.基质金属蛋白酶与冠脉再狭窄[J].心脏杂志,2005,17(1):77-80. 被引量:5
-
2杨猛,潘港,孟凡强,曾维理.冠心病患者常规支架术和直接支架术后MMP-9的变化及意义[J].医学临床研究,2005,22(10):1421-1423.
-
3刘贵波,李志强,成永霞.金属基质蛋白酶与动脉粥样硬化[J].牡丹江医学院学报,2006,27(4):56-57. 被引量:1
-
4马小峰,潘港,蔺雪峰.冠心病患者常规支架术和直接支架术后血清MMP-9、P-选择素浓度的变化[J].南华大学学报(医学版),2006,34(3):351-353.
-
5裴强,吴阳,马钢,解坤,赵习德.桂枝茯苓胶囊干预大鼠心脏微小血管重塑的机制研究[J].河南医学研究,2019,28(7):1153-1157. 被引量:3
-
1涂悦,马铁柱,吴绘.基质金属蛋白酶与脑缺血研究进展[J].医学综述,2006,12(1):55-57. 被引量:4
-
2杨晨辉,范洪光,刘莹,张祥建.基质金属蛋白酶与出血性转化[J].国际脑血管病杂志,2008,16(4):285-288. 被引量:1
-
3李杰,李光勤.基质金属蛋白酶与溶栓后出血性转化[J].国外医学(内科学分册),2006,33(4):173-176. 被引量:3
-
4杨立艳,贾凤玖,刘大成.丹参川芎嗪注射液对冠状动脉介入治疗后C反应蛋白的影响[J].血栓与止血学,2013,19(6):277-278.
-
5张羚.阿托伐他汀治疗急性缺血性脑卒中患者颈动脉粥样硬化斑块临床研究[J].中国实用神经疾病杂志,2016,19(3):73-75. 被引量:14
-
6金鑫,佟丽妍,许莉,秋超,侯群.乌司他丁对脑出血的治疗作用[J].现代实用医学,2013,25(3):358-360. 被引量:3
-
7谢清,陈衔城.脑动静脉畸形血管重构的分子生物学机制[J].中国临床神经科学,2006,14(1):110-112.
-
8李方江,张凡,岳炳红,王永丽,徐涛,宋郁珍,李会贤,杨文粹.冠状动脉介入术后抑郁障碍及心理干预研究[J].中国实用医药,2008,3(23):56-57. 被引量:2
-
9涂悦,李玉明.基质金属蛋白酶及其抑制剂与脑血管疾病[J].国际神经病学神经外科学杂志,2005,32(5):447-451. 被引量:4
-
10任鸿萍.冠状动脉介入术后再发脑卒中的危险因素分析[J].中国实用神经疾病杂志,2016,19(3):56-57. 被引量:4